Sinil Pharmaceutical Co Ltd (012790)

Currency in KRW
6,120
+10(+0.16%)
Closed·
012790 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6,0806,140
52 wk Range
4,8206,820
Key Statistics
Bid/Ask
6,050.00 / 6,180.00
Prev. Close
6,120
Open
6,110
Day's Range
6,080-6,140
52 wk Range
4,820-6,820
Volume
5.08K
Average Volume (3m)
17.28K
1-Year Change
-1.1309%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
012790 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
193.97 / --
Revenue / Forecast
24.2B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 555.26%
Dividend Yield
3.11%
Industry Median 1.11%
Annualized payout
190.00
Paid annually
5-Years Growth
-
Growth Streak

012790 Income Statement

Compare 012790 to Peers and Sector

Metrics to compare
012790
Peers
Sector
Relationship
P/E Ratio
10.8x8.1x−0.4x
PEG Ratio
−0.250.020.00
Price/Book
0.5x0.5x2.6x
Price / LTM Sales
0.8x0.7x3.0x
Upside (Analyst Target)
-52.0%57.0%
Fair Value Upside
Unlock20.9%8.0%Unlock

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.

Employees
287

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
39.99K0.35%244.76M
Other Institutional Investors
6.56K0.06%40.17M
Public Companies & Retail Investors
11.33M99.59%69.34B
Total
11.38M100.00%69.62B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dimensional Fund Advisors LP0.35%39,993244,757
DFA Investment Dimensions Group Inc. - Emerging Markets Core Equity 2 Portfolio0.20%22,549138,000

People Also Watch

184,600
005830
-0.70%
520,000
128940
+3.59%
95,800
005300
+0.95%
83,300
012750
-0.12%
60,300
006120
+4.87%

FAQ

What Is the Sinil Pharmaceutical (012790) Stock Price Today?

The Sinil Pharmaceutical stock price today is 6,120 KRW.

What Stock Exchange Does Sinil Pharmaceutical Trade On?

Sinil Pharmaceutical is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Sinil Pharmaceutical?

The stock symbol for Sinil Pharmaceutical is "012790."

Does Sinil Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Sinil Pharmaceutical dividend yield is 3.11%.

What Is the Sinil Pharmaceutical Market Cap?

As of today, Sinil Pharmaceutical market cap is 69.62B KRW.

What Is Sinil Pharmaceutical's Earnings Per Share (TTM)?

The Sinil Pharmaceutical EPS (TTM) is 555.

From a Technical Analysis Perspective, Is 012790 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sinil Pharmaceutical Stock Split?

Sinil Pharmaceutical has split 5 times.

How Many Employees Does Sinil Pharmaceutical Have?

Sinil Pharmaceutical has 287 employees.

What is the current trading status of Sinil Pharmaceutical (012790)?

As of Sep 25, 2026, Sinil Pharmaceutical (012790) is trading at a price of 6,120 KRW, with a previous close of 6,120 KRW. The stock has fluctuated within a day range of 6,080 KRW to 6,140 KRW, while its 52-week range spans from 4,820 KRW to 6,820 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.